Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers
- PMID: 9657753
Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers
Abstract
von Willebrand factor (vWF) is a multimeric adhesive glycoprotein with one factor VIII binding site/subunit. Prior reports suggest that posttranslational modifications of vWF, including formation of N-terminal intersubunit disulfide bonds and subsequent cleavage of the propeptide, influence availability and/or affinity of factor VIII binding sites. We found that deletion of the vWF propeptide produced a dimeric vWF molecule lacking N-terminal intersubunit disulfide bonds. This molecule bound fluorescein-labeled factor VIII with sixfold lower affinity than multimeric vWF in an equilibrium flow cytometry assay (approximate KDs, 5 nmol/L v 0.9 nmol/L). Coexpression of propeptide-deleted vWF with the vWF propeptide in trans yielded multimeric vWF that displayed increased affinity for factor VIII. Insertion of an alanine residue at the N-terminus of the mature vWF subunit destroyed binding to factor VIII, indicating that the native mature N-terminus is required for factor VIII binding. The requirement for vWF propeptide cleavage was shown by (1) a point mutation of the vWF propeptide cleavage site yielding pro-vWF that was defective in factor VIII binding and (2) correlation between efficiency of intracellular propeptide cleavage and factor VIII binding. Furthermore, in a cell-free system, addition of the propeptide-cleaving enzyme PACE/furin enabled factor VIII binding in parallel with propeptide cleavage. Our results indicate that high-affinity factor VIII binding sites are located on N-terminal disulfide-linked vWF subunits from which the propeptide has been cleaved.
Similar articles
-
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.J Biol Chem. 1991 Nov 15;266(32):21948-55. J Biol Chem. 1991. PMID: 1939217
-
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.Blood. 2003 Jan 1;101(1):151-6. doi: 10.1182/blood-2002-04-1046. Epub 2002 Aug 8. Blood. 2003. PMID: 12393698
-
Molecular genetics of von Willebrand disease.Ann Genet. 1998;41(1):34-43. Ann Genet. 1998. PMID: 9599650 Review.
-
Disulfide bonds required to assemble functional von Willebrand factor multimers.J Biol Chem. 1994 Mar 4;269(9):6753-8. J Biol Chem. 1994. PMID: 8120035
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
Cited by
-
Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors.Haemophilia. 2014 Nov;20(6):905-11. doi: 10.1111/hae.12494. Epub 2014 Aug 25. Haemophilia. 2014. PMID: 25156825 Free PMC article.
-
von Willebrand factor regulation of blood vessel formation.Blood. 2018 Jul 12;132(2):132-140. doi: 10.1182/blood-2018-01-769018. Epub 2018 Jun 4. Blood. 2018. PMID: 29866817 Free PMC article. Review.
-
Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.J Biol Chem. 2013 Jan 4;288(1):393-400. doi: 10.1074/jbc.M112.400572. Epub 2012 Nov 20. J Biol Chem. 2013. PMID: 23168412 Free PMC article.
-
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.Mol Ther Methods Clin Dev. 2018 Dec 31;12:184-201. doi: 10.1016/j.omtm.2018.12.007. eCollection 2019 Mar 15. Mol Ther Methods Clin Dev. 2018. PMID: 30705923 Free PMC article. Review.
-
A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.Nanoscale. 2014 May 7;6(9):4765-73. doi: 10.1039/c3nr06400j. Nanoscale. 2014. PMID: 24658160 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous